Literature DB >> 11483519

Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis.

D Matas1, A Sigal, P Stambolsky, M Milyavsky, L Weisz, D Schwartz, N Goldfinger, V Rotter.   

Abstract

The present study examined whether the ability of mutant p53 to block apoptosis depended on its transcriptional activity. A core domain mutant p53 (143 Val to Ala), in which two N-terminal residues (22 and 23) essential for transactivation were also mutated (Leu to Glu and Trp to Ser, respectively), was examined. While p53 containing only the core mutation efficiently interfered with drug-induced apoptosis, further modification at the N-terminus abolished this blocking activity. Furthermore, expression of c-myc, a suggested target for core mutant p53 transactivation, was elevated in the core mutant p53-expressing cells, but was abolished in the presence of the transcription-deficient p53 core mutant. In addition, wild-type p53, mutated in the N-terminus (residues 22 and 23), was unable to induce apoptosis by itself. Nevertheless, it synergized with drugs in the induction of apoptosis. This suggests that the integrity of the N-terminus is essential for both the activity of wild-type p53 in apoptosis and for mutant p53-mediated block of drug-induced apoptosis. This supports the notion that core p53 mutants act via a gain of function mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483519      PMCID: PMC149170          DOI: 10.1093/emboj/20.15.4163

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  88 in total

1.  Analysis of JNK, Mdm2 and p14(ARF) contribution to the regulation of mutant p53 stability.

Authors:  T Buschmann; T Minamoto; N Wagle; S Y Fuchs; V Adler; M Mai; Z Ronai
Journal:  J Mol Biol       Date:  2000-01-28       Impact factor: 5.469

Review 2.  The dual role model for p53 in maintaining genomic integrity.

Authors:  F Janus; N Albrechtsen; I Dornreiter; L Wiesmüller; F Grosse; W Deppert
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

3.  Inhibition of RNA polymerase II as a trigger for the p53 response.

Authors:  M Ljungman; F Zhang; F Chen; A J Rainbow; B C McKay
Journal:  Oncogene       Date:  1999-01-21       Impact factor: 9.867

4.  Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc.

Authors:  M D Sklar; E V Prochownik
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

Review 5.  p53-dependent cell cycle control: response to genotoxic stress.

Authors:  D Schwartz; V Rotter
Journal:  Semin Cancer Biol       Date:  1998       Impact factor: 15.707

Review 6.  A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.

Authors:  D A Gewirtz
Journal:  Biochem Pharmacol       Date:  1999-04-01       Impact factor: 5.858

7.  Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.

Authors:  Y I Lee; S Lee; G C Das; U S Park; S M Park; Y I Lee
Journal:  Oncogene       Date:  2000-08-03       Impact factor: 9.867

Review 8.  Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens.

Authors:  S P Hussain; C C Harris
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

9.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

10.  Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy.

Authors:  G Blandino; A J Levine; M Oren
Journal:  Oncogene       Date:  1999-01-14       Impact factor: 9.867

View more
  37 in total

1.  Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation.

Authors:  Nuha Mahmoud; Mohamed E M Saeed; Yoshikazu Sugimoto; Sabine M Klauck; Henry J Greten; Thomas Efferth
Journal:  Oncotarget       Date:  2018-11-06

Review 2.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

3.  Pla2g16 phospholipase mediates gain-of-function activities of mutant p53.

Authors:  Shunbin Xiong; Huolin Tu; Madhusudhan Kollareddy; Vinod Pant; Qin Li; Yun Zhang; James G Jackson; Young-Ah Suh; Ana C Elizondo-Fraire; Peirong Yang; Gilda Chau; Mehrnoosh Tashakori; Amanda R Wasylishen; Zhenlin Ju; Hilla Solomon; Varda Rotter; Bin Liu; Adel K El-Naggar; Lawrence A Donehower; Luis Alfonso Martinez; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

4.  Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.

Authors:  Eyal Kalo; Yosef Buganim; Keren E Shapira; Hilla Besserglick; Naomi Goldfinger; Lilach Weisz; Perry Stambolsky; Yoav I Henis; Varda Rotter
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

5.  In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation.

Authors:  Susan Erster; Motohiro Mihara; Roger H Kim; Oleksi Petrenko; Ute M Moll
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

6.  Tumor suppressor and T-regulatory functions of Foxp3 are mediated through separate signaling pathways.

Authors:  Emil Heinze; Grace Chan; Rachel Mory; Raz Khavari; Asif Alavi; Sue Y Chung; Robert N Nishimura; Richard H Weisbart
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

Review 7.  Contribution of p53 to metastasis.

Authors:  Emily Powell; David Piwnica-Worms; Helen Piwnica-Worms
Journal:  Cancer Discov       Date:  2014-03-21       Impact factor: 39.397

8.  p53 Amino-terminus region (1-125) stabilizes and restores heat denatured p53 wild phenotype.

Authors:  Anuj Kumar Sharma; Amjad Ali; Rajan Gogna; Amir Kumar Singh; Uttam Pati
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

9.  Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences.

Authors:  Marie Brázdová; Timo Quante; Lars Tögel; Korden Walter; Christine Loscher; Vlastimil Tichý; Lenka Cincárová; Wolfgang Deppert; Genrich V Tolstonog
Journal:  Nucleic Acids Res       Date:  2009-01-12       Impact factor: 16.971

10.  Mutant p53 mediates survival of breast cancer cells.

Authors:  L Y Lim; N Vidnovic; L W Ellisen; C-O Leong
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.